| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| CREBBP | EP300 | ENSOGAP00000002066 | ENSOGAP00000000381 | CREB binding protein. | E1A binding protein p300. | 0.999 |
| CREBBP | H0XPU8_OTOGA | ENSOGAP00000002066 | ENSOGAP00000018139 | CREB binding protein. | BTB_2 domain-containing protein. | 0.683 |
| CREBBP | H0XQT3_OTOGA | ENSOGAP00000002066 | ENSOGAP00000018475 | CREB binding protein. | Small ubiquitin-related modifier. | 0.621 |
| CREBBP | H0Y0J5_OTOGA | ENSOGAP00000002066 | ENSOGAP00000021888 | CREB binding protein. | Small ubiquitin-related modifier. | 0.966 |
| CREBBP | KCTD2 | ENSOGAP00000002066 | ENSOGAP00000022291 | CREB binding protein. | BTB domain-containing protein. | 0.683 |
| CREBBP | SUMO1 | ENSOGAP00000002066 | ENSOGAP00000019503 | CREB binding protein. | Ubiquitin-like domain-containing protein. | 0.947 |
| CREBBP | SUMO3 | ENSOGAP00000002066 | ENSOGAP00000004215 | CREB binding protein. | Small ubiquitin-related modifier. | 0.621 |
| CREBBP | TDG | ENSOGAP00000002066 | ENSOGAP00000015235 | CREB binding protein. | Thymine DNA glycosylase. | 0.964 |
| CREBBP | TP53 | ENSOGAP00000002066 | ENSOGAP00000015106 | CREB binding protein. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. | 0.997 |
| CREBBP | UBE2I | ENSOGAP00000002066 | ENSOGAP00000001269 | CREB binding protein. | Ubiquitin conjugating enzyme E2 I; Belongs to the ubiquitin-conjugating enzyme family. | 0.963 |
| EP300 | CREBBP | ENSOGAP00000000381 | ENSOGAP00000002066 | E1A binding protein p300. | CREB binding protein. | 0.999 |
| EP300 | H0XPU8_OTOGA | ENSOGAP00000000381 | ENSOGAP00000018139 | E1A binding protein p300. | BTB_2 domain-containing protein. | 0.683 |
| EP300 | H0XQT3_OTOGA | ENSOGAP00000000381 | ENSOGAP00000018475 | E1A binding protein p300. | Small ubiquitin-related modifier. | 0.639 |
| EP300 | H0Y0J5_OTOGA | ENSOGAP00000000381 | ENSOGAP00000021888 | E1A binding protein p300. | Small ubiquitin-related modifier. | 0.869 |
| EP300 | KCTD2 | ENSOGAP00000000381 | ENSOGAP00000022291 | E1A binding protein p300. | BTB domain-containing protein. | 0.683 |
| EP300 | SUMO1 | ENSOGAP00000000381 | ENSOGAP00000019503 | E1A binding protein p300. | Ubiquitin-like domain-containing protein. | 0.866 |
| EP300 | SUMO3 | ENSOGAP00000000381 | ENSOGAP00000004215 | E1A binding protein p300. | Small ubiquitin-related modifier. | 0.639 |
| EP300 | TDG | ENSOGAP00000000381 | ENSOGAP00000015235 | E1A binding protein p300. | Thymine DNA glycosylase. | 0.856 |
| EP300 | TP53 | ENSOGAP00000000381 | ENSOGAP00000015106 | E1A binding protein p300. | Cellular tumor antigen p53; Acts as a tumor suppressor in many tumor types; induces growth arrest or apoptosis depending on the physiological circumstances and cell type. Involved in cell cycle regulation as a trans-activator that acts to negatively regulate cell division by controlling a set of genes required for this process. One of the activated genes is an inhibitor of cyclin-dependent kinases. Apoptosis induction seems to be mediated either by stimulation of BAX and FAS antigen expression, or by repression of Bcl-2 expression; Belongs to the p53 family. | 0.997 |
| EP300 | UBE2I | ENSOGAP00000000381 | ENSOGAP00000001269 | E1A binding protein p300. | Ubiquitin conjugating enzyme E2 I; Belongs to the ubiquitin-conjugating enzyme family. | 0.890 |
